A low-cost, widely available drug may offer new hope for patients with severe COVID-19. An international study led by the ...

A meta-trial of randomized clinical studies across six countries has found that inhaled heparin significantly reduced the ...

Heparin, a widely available drug traditionally used to treat blood clots, lowers risk of death and ventilation in patients ...

Cheap, abundant man-made chemical compound is found in blood thinner. March 19, 2008 — -- Investigators believe they have discovered what's contaminating the blood-thinning medication heparin and ...

Inhaled heparin significantly lowers the risk of death and ventilation in COVID-19 patients while also showing potential ...

A widely available and affordable drug has been shown to be effective in treating seriously ill COVID-19 patients, according to a new international study led by researchers at the Australian National ...

Early retrospective reports suggested alarmingly high incidences of pulmonary embolism among patients who were hospitalized for Covid-19. However, those studies preferentially included patients who ...

FDA announced on March 19 that in collaboration with academic labs it has identified a contaminant in heparin linked to severe allergic reactions to the drug. The contaminant is chondroitin sulfate ...

A meta-trial of randomized clinical studies conducted in 6 countries suggests that the use of inhaled heparin dramatically reduced the risk of intubation, death, and in-hospital death in hospitalized ...

CorMedix’s CRMD lead drug, DefenCath (Taurolidine + Heparin), is currently its only marketed product that generates revenues ...

Researchers at the Spanish National Research Council (CSIC) Institute for Advanced Chemistry of Catalonia (IQAC-CSIC) have discovered and synthesized a number of molecules that inhibit the effects of ...